In this study, we found that CRABP2 is highly expressed in ovarian cancer tissues and is associated with the malignancy of the tumor and the prognosis of ovarian cancer patients, and that CRABP2 expression level is related to the sensitivity of ovarian cancer cells to chemotherapy drugs. The gene discussed is CRABP2; the disease is ovarian cancer.